Open Payments

Saint Louis Heart and Vascular

Type
Non-covered entity
Where
Bridgeton, MO
Received
$658,630 in 114 records, 2019 to 2024 ($0 general, $658,630 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2024Research payment7$214,041
2023Research payment5$145,119
2021Research payment13$29,632
2020Research payment41$149,530
2019Research payment48$120,308

By company

CompanyRecordsAmountYears
Janssen Research & Development, LLC12$359,1602023–2024
Bayer Healthcare Pharmaceuticals Inc.102$299,4702019–2021

By nature of payment

NatureRecordsAmount
Research payment114$658,630

Records

DateCompanyAmountNatureFormProductStudyYear
2024-06-25Janssen Research & Development, LLC$8,330Research paymentCash or cash equivalent70033093AFL30022024
2024-06-14Janssen Research & Development, LLC$34,479Research paymentCash or cash equivalent70033093AFL30022024
2024-05-22Janssen Research & Development, LLC$27,907Research paymentCash or cash equivalent70033093AFL30022024
2024-04-26Janssen Research & Development, LLC$41,713Research paymentCash or cash equivalent70033093AFL30022024
2024-03-25Janssen Research & Development, LLC$23,153Research paymentCash or cash equivalent70033093AFL30022024
2024-03-04Janssen Research & Development, LLC$40,612Research paymentCash or cash equivalent70033093AFL30022024
2024-01-26Janssen Research & Development, LLC$37,847Research paymentCash or cash equivalent70033093AFL30022024
2023-12-20Janssen Research & Development, LLC$4,163Research paymentCash or cash equivalent70033093AFL30022023
2023-12-15Janssen Research & Development, LLC$34,477Research paymentCash or cash equivalent70033093AFL30022023
2023-11-17Janssen Research & Development, LLC$57,674Research paymentCash or cash equivalent70033093AFL30022023
2023-10-25Janssen Research & Development, LLC$36,919Research paymentCash or cash equivalent70033093AFL30022023
2023-09-15Janssen Research & Development, LLC$11,886Research paymentCash or cash equivalent70033093AFL30022023
2021-07-19Bayer Healthcare Pharmaceuticals Inc.$2,000Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-07-19Bayer Healthcare Pharmaceuticals Inc.$2,000Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-07-19Bayer Healthcare Pharmaceuticals Inc.$1,405Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-07-19Bayer Healthcare Pharmaceuticals Inc.$1,405Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-07-19Bayer Healthcare Pharmaceuticals Inc.$1,405Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-07-14Bayer Healthcare Pharmaceuticals Inc.$2,000Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-07-06Bayer Healthcare Pharmaceuticals Inc.$5,000Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-02-03Bayer Healthcare Pharmaceuticals Inc.$3,432Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-02-03Bayer Healthcare Pharmaceuticals Inc.$3,432Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-02-03Bayer Healthcare Pharmaceuticals Inc.$3,432Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-02-03Bayer Healthcare Pharmaceuticals Inc.$2,743Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-02-03Bayer Healthcare Pharmaceuticals Inc.$689Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2021-02-03Bayer Healthcare Pharmaceuticals Inc.$689Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2021
2020-12-10Bayer Healthcare Pharmaceuticals Inc.$2,743Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-12-10Bayer Healthcare Pharmaceuticals Inc.$2,743Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-12-10Bayer Healthcare Pharmaceuticals Inc.$2,743Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-10-22Bayer Healthcare Pharmaceuticals Inc.$1,500Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-10-14Bayer Healthcare Pharmaceuticals Inc.$3,000Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-10-14Bayer Healthcare Pharmaceuticals Inc.$3,000Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-10-14Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-10-14Bayer Healthcare Pharmaceuticals Inc.$559Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-09-16Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-08-12Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-08-12Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-08-12Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-07-14Bayer Healthcare Pharmaceuticals Inc.$4,215Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-07-14Bayer Healthcare Pharmaceuticals Inc.$2,000Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-07-14Bayer Healthcare Pharmaceuticals Inc.$500Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-07-13Bayer Healthcare Pharmaceuticals Inc.$3,000Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-06-17Bayer Healthcare Pharmaceuticals Inc.$37,778Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-06-12Bayer Healthcare Pharmaceuticals Inc.$5,000Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-06-12Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-06-12Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-05-11Bayer Healthcare Pharmaceuticals Inc.$689Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-05-11Bayer Healthcare Pharmaceuticals Inc.$689Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-05-08Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-04-21Bayer Healthcare Pharmaceuticals Inc.$3,432Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-04-21Bayer Healthcare Pharmaceuticals Inc.$3,432Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-04-21Bayer Healthcare Pharmaceuticals Inc.$3,432Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-04-21Bayer Healthcare Pharmaceuticals Inc.$3,432Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-04-21Bayer Healthcare Pharmaceuticals Inc.$2,743Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-04-21Bayer Healthcare Pharmaceuticals Inc.$2,743Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-04-08Bayer Healthcare Pharmaceuticals Inc.$11,893Research paymentCash or cash equivalentNon-CoveredVericiguat in HFpEF2020
2020-04-08Bayer Healthcare Pharmaceuticals Inc.$3,000Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-04-08Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-04-08Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-03-06Bayer Healthcare Pharmaceuticals Inc.$5,743Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-03-06Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-02-03Bayer Healthcare Pharmaceuticals Inc.$3,000Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-02-03Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2020
2020-01-30Bayer Healthcare Pharmaceuticals Inc.$3,000Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-01-30Bayer Healthcare Pharmaceuticals Inc.$3,000Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-01-30Bayer Healthcare Pharmaceuticals Inc.$3,000Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2020-01-30Bayer Healthcare Pharmaceuticals Inc.$2,117Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2020
2019-12-13Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-12-13Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-12-13Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-12-13Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-11-15Bayer Healthcare Pharmaceuticals Inc.$28,647Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-11-04Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-11-04Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-11-04Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-11-04Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-09-09Bayer Healthcare Pharmaceuticals Inc.$5,079Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-09-09Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-09-09Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-09-09Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-09-09Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-09-06Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-09-06Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-09-06Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-09-06Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-06-21Bayer Healthcare Pharmaceuticals Inc.$1,800Research paymentCash or cash equivalentNon-CoveredVericiguat in HFpEF2019
2019-06-12Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-06-12Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-06-12Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-06-12Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-06-12Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-06-11Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-06-11Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-06-11Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-05-20Bayer Healthcare Pharmaceuticals Inc.$1,704Research paymentCash or cash equivalentNon-CoveredVericiguat in HFpEF2019
2019-05-20Bayer Healthcare Pharmaceuticals Inc.$430Research paymentCash or cash equivalentNon-CoveredVericiguat in HFpEF2019
2019-05-06Bayer Healthcare Pharmaceuticals Inc.$2,710Research paymentCash or cash equivalentNon-CoveredVericiguat in HFpEF2019
2019-05-06Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-05-06Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-05-06Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-05-06Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-03-12Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-03-12Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-03-12Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-03-12Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-03-12Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-03-12Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY 94-8862 ph 3 conventional in diab nephropathy2019
2019-03-07Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-03-07Bayer Healthcare Pharmaceuticals Inc.$2,400Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-03-07Bayer Healthcare Pharmaceuticals Inc.$1,800Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-03-07Bayer Healthcare Pharmaceuticals Inc.$1,800Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-03-07Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-03-07Bayer Healthcare Pharmaceuticals Inc.$1,693Research paymentCash or cash equivalentNon-CoveredBAY94-8862 ph 3 conventional in diabetic nephropathy2019
2019-01-22Bayer Healthcare Pharmaceuticals Inc.$1,146Research paymentCash or cash equivalentNon-CoveredVericiguat in HFpEF2019
2019-01-22Bayer Healthcare Pharmaceuticals Inc.$960Research paymentCash or cash equivalentNon-CoveredVericiguat in HFpEF2019

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

St. Louis CountyBridgeton city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Bridgeton, MO, county St. Louis County, MO, state Missouri; placed by its city name.

MeasurePlace (city or town)
Bridgeton, MO
County
St. Louis County, MO
State
Missouri
Population B0100311,369995,5696,191,814
Population, 2020 census P111,4451,004,1256,154,913
Median age B0100240.940.339.0
Under 18 B0100121.8%22.0%22.3%
65 and over B0100121.5%19.1%17.9%
Households B110014,747413,8492,508,227
Foreign born B0500213.9%8.4%4.5%
Median household income B19013$72,005$82,936$70,702
Median family income B19113$83,153$110,950$91,360
Per capita income B19301$39,809$51,977$39,695
Poverty rate B1700111.5%9.8%12.6%
Unemployment rate B230253.2%4.3%4.0%
Civilian labor force B230255,774521,3873,120,639
Mean commute (minutes) B0801321.223.123.5
Bachelor's degree or higher B1500336.0%47.4%32.4%
Housing units B250015,066446,1922,825,287
Owner-occupied B2500363.1%69.2%68.1%
Renters B2500336.9%30.8%31.9%
Median home value B25077$237,700$276,800$230,300
Median gross rent B25064$1,172$1,209$1,033
White, not Hispanic B0300255.8%61.4%76.3%
Black B0300223.7%24.0%10.9%
Hispanic or Latino B0300213.8%3.9%5.2%
Asian B030022.7%4.9%2.1%
American Indian and Alaska Native B030020.0%0.1%0.2%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Bridgeton, MO.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.